APA (7th ed.) Citation

CL, M., A, H., P, S., A, R., J, M., A, G., . . . B, S. (2022). Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab. Frontiers in immunology, 13, 966236. https://doi.org/10.3389/fimmu.2022.966236

Chicago Style (17th ed.) Citation

CL, Magnus, Hiergeist A, Schuster P, Rohrhofer A, Medenbach J, Gessner A, Peterhoff D, and Schmidt B. "Targeted Escape of SARS-CoV-2 in Vitro from Monoclonal Antibody S309, the Precursor of Sotrovimab." Frontiers in Immunology 13 (2022): 966236. https://doi.org/10.3389/fimmu.2022.966236.

MLA (9th ed.) Citation

CL, Magnus, et al. "Targeted Escape of SARS-CoV-2 in Vitro from Monoclonal Antibody S309, the Precursor of Sotrovimab." Frontiers in Immunology, vol. 13, 2022, p. 966236, https://doi.org/10.3389/fimmu.2022.966236.